Suguru Kadomoto Selected Research

Castration

10/2023	Role of Positive Biopsy Core Ratio in Prostate Cancer Patients.
6/2023	The CCL2-CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells.
6/2023	Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells.
4/2023	Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
3/2023	Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents?
11/2022	Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study.
9/2022	Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.
2/2022	Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer.
1/2022	Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report.
5/2021	Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suguru Kadomoto Research Topics

Disease

24	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2018
15	Neoplasms (Cancer) 04/2024 - 01/2018
9	Neoplasm Metastasis (Metastasis) 06/2023 - 02/2017
3	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 09/2022
3	Sarcopenia 06/2023 - 05/2021
3	Urologic Neoplasms (Urological Cancer) 01/2023 - 01/2022
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2023 - 05/2023
2	COVID-19 01/2023 - 04/2022
2	Neutropenia 01/2023 - 01/2021
2	Kidney Neoplasms (Kidney Cancer) 11/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 11/2021 - 01/2019
2	Inflammation (Inflammations) 08/2021 - 07/2020
1	Hypotension (Low Blood Pressure) 04/2024
1	Urinary Bladder Calculi (Bladder Calculi) 03/2024
1	Non-Muscle Invasive Bladder Neoplasms 06/2023
1	Hypoalbuminemia 06/2023
1	Febrile Neutropenia 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Pneumoperitoneum 09/2022
1	Embolism (Embolus) 09/2022
1	Air Embolism (Gas Embolism) 09/2022
1	Hemorrhage 06/2022
1	Microsatellite Instability 01/2022
1	Small Cell Carcinoma 01/2022
1	Pathologic Complete Response 01/2022
1	Lymphocele 09/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021
1	Pelvic Organ Prolapse 01/2021
1	Hypertension (High Blood Pressure) 07/2020
1	Disease Progression 02/2020
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2020
1	Urachal cancer 08/2019

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 11/2022 - 03/2018
5	AndrogensIBA 06/2023 - 01/2018
5	cabazitaxel FDA Link 06/2023 - 03/2018
5	Androgen Receptors (Androgen Receptor)IBA 04/2023 - 03/2018
4	CC ChemokinesIBA 11/2022 - 05/2018
4	ChemokinesIBA 08/2021 - 03/2018
3	Docetaxel (Taxotere)FDA Link 06/2023 - 01/2019
3	Hormones (Hormone)IBA 03/2023 - 11/2018
3	Prostate-Specific Antigen (Semenogelase)IBA 11/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2022
2	pembrolizumabIBA 04/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 05/2019
2	DiterpenesIBA 12/2021 - 01/2019
2	kahweol acetateIBA 12/2021 - 01/2019
2	cafestolIBA 12/2021 - 01/2019
2	Coffee FDA Link 12/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2019
1	AcidsIBA 04/2024
1	Chalcone (Benzalacetophenone)IBA 06/2023
1	AlbuminsIBA 06/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	Small Interfering RNA (siRNA)IBA 04/2023
1	Carbon DioxideIBA 09/2022
1	COVID-19 VaccinesIBA 04/2022
1	VaccinesIBA 04/2022
1	kahweolIBA 12/2021
1	PlatinumIBA 11/2021
1	CytokinesIBA 08/2021
1	Chemotactic FactorsIBA 08/2021
1	pegfilgrastim (Neulasta)FDA Link 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	FlavonoidsIBA 01/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	2'-hydroxyflavanoneIBA 01/2021
1	taxaneIBA 01/2021
1	indium-bleomycinIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 07/2020
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 07/2020
1	Antihypertensive Agents (Antihypertensives)IBA 07/2020
1	Testosterone (Sustanon)FDA Link 01/2020
1	Gemcitabine FDA Link 08/2019
1	Tumor Biomarkers (Tumor Markers)IBA 08/2019
1	enzalutamideIBA 05/2019
1	Abiraterone AcetateIBA 05/2019
1	CarbohydratesIBA 01/2019
1	Caffeine (No Doz)FDA LinkGeneric 01/2019
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2019
1	Chlorogenic AcidIBA 01/2019
1	trigonellineIBA 01/2019
1	caffeic acidIBA 01/2019
1	big gastrinIBA 11/2018

Therapy/Procedure

15	Castration 10/2023 - 03/2018
12	Therapeutics 06/2023 - 11/2018
9	Drug Therapy (Chemotherapy) 01/2023 - 01/2018
4	Transurethral Resection of Bladder 04/2024 - 09/2022
4	Nephrectomy 06/2023 - 06/2022
3	Oral Administration 04/2024 - 01/2019
3	Combination Drug Therapy (Combination Chemotherapy) 11/2021 - 08/2019
2	Brachytherapy 03/2024 - 01/2020
1	General Anesthesia 04/2024
1	Spinal Anesthesia 04/2024
1	Prostatectomy (Retropubic Prostatectomy) 01/2023
1	Hand Hygiene 01/2023
1	Cryosurgery 11/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2022
1	Lymph Node Excision (Lymph Node Dissection) 09/2021
1	Radiotherapy 08/2019